Psychiatric complications of Ma-huang

Psychosomatics

Volumn 41, Issue 1, 2000, Pages 58-62

  Jacobs, Karl M ^a   Hirsch, Kenneth A ^b  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; BENZATROPINE MESILATE; EPHEDRINE; FLUOXETINE; HALOPERIDOL; OLANZAPINE; PAROXETINE; PLANT EXTRACT; PSYCHOSTIMULANT AGENT; SERTRALINE; UNCLASSIFIED DRUG;

ADULT; AFFECTIVE NEUROSIS; ARTICLE; CASE REPORT; CLINICAL FEATURE; DEPRESSION; DIET SUPPLEMENTATION; DISEASE COURSE; EPHEDRA; HUMAN; MALE; PSYCHOSIS;

EID: 0033965048     PISSN: 00333182     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0033-3182(00)71174-1     Document Type: Letter

References (20)

1. DerMardrosian A, Liberti L: The Ephedras, in The Lawrence Review of Natural Products, edited by Olin BR. St. Louis, MO, Facts and Comparisons, 1995, pp 1-2
2. Dietary supplements containing ephedrine alkaloids. Federal Register, June 4, 1997, (Vol 62, No. 07), Proposed Rules, Pages 30677-30724. Federal Register Online via GPO [wais.access.gpo.gov]. Available: http://frwebgate3.access.gpo.gov/cgi-bin/waisgate.cgi? WAISdocID = 1166732718 + 0 + 0 + 0&WAISaction = retrieve. (Accessed on 1/7/99)
3. Eisenberg DM, Davis RB, Ettner SL, et al: Trends in alternative medicine use in the United States, 1990-1997. JAMA 1998; 280: 1569-1575
4. Josefson D: Herbal stimulant causes U.S. deaths (news brief). BMJ 1996; 312:1441
5. Crone CC, Wise TN: Use of herbal medicines among consultation-liaison populations: a review of current information regarding risks, interactions, and efficacy. Psychosomatics 1998; 39:3-13
6. Kaptchuk TJ, Eisenberg DM: The persuasive appeal of alternative medicine. Ann Intern Med 1998; 129:1061-1065
7. Herridge CF, O'Brook MF: Ephedrine psychosis (case report). BMJ 1968; 2:160
8. Whitehouse AM, Duncan JM: Ephedrine psychosis rediscovered. Br J Psychiatry 1987; 150:258-261
9. Roxanas MG, Spalding J: Ephedrine abuse psychosis. Med J Aust 1977; 2:639-640
10. Doyle H, Kargin M: Herbal stimulant containing ephedrine has also caused psychosis (letter). BMJ 1996; 313:756
11. Lake CR, Tenglin R, Chernow B, et al: Psychomotor stimulant-induced mania in a genetically predisposed patient: a review of the literature and a report of a case. J Clin Psychopharmacol 1983; 3:97-100
12. Capwell RR: Ephedrine-induced mania from an herbal diet supplement (letter). Am J Psychiatry 1995; 152:647
13. Brunteton J: Phenethylamines, in Pharmacognosy, Phytochemistry, and Medicinal Plants. Edited by Hatton CK (translated). Paris, France, Lavoisier, 1995, pp 711-715
14. Chen KK, Schmidt CF: Ephedrine and related substances. Medicine 1930; 9:117
15. Hoffman BB, Lefkowitz RJ: Catecholeamines and sympathomimetic drugs, in The Pharmacological Basis of Therapeutics. Edited by Gilman AG, Rall TW, Nies AS, et al. New York, Pergamon, 1990, pp 187-220
16. Angrist B, Rotroson J, Kleinberg D, et al: Dopaminergic agonist properties of ephedrine: theoretical implications. Psychopharmacology 1977; 55:115-120
17. Martin WR, Sloan JW, Sapira JD, et al: Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin Pharmacol Ther 1970; 12:245-258
18. Chait LD: Factors influencing the reinforcing and subjective effects of ephedrine in humans. Psychopharmacology 1994; 113:381-387
19. Dougherty RJ: Pseudo-speed: look-alikes or peashooters. NY State Journal of Medicine 1982; 1:74-75
20. Lake CR, Quirk RS: CNS stimulants and the look-alike drugs. Psychiatr Clin North Am 1984; 7:689-701